Company Filing History:
Years Active: 2006
Title: David Robert Luthin: Innovator in Non-Peptide GnRH Agents
Introduction
David Robert Luthin is a notable inventor based in Encinitas, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of non-peptide GnRH agents. His work focuses on addressing reproductive disorders and hormone-dependent tumors.
Latest Patents
Luthin holds a patent for "Non-peptide GnRH agents, methods and intermediates for their preparation." This patent describes non-peptide GnRH agents that can inhibit the effects of gonadotropin-releasing hormone. These compounds, along with their pharmaceutically acceptable salts, multimers, prodrugs, and active metabolites, are suitable for treating mammalian reproductive disorders and regulating fertility. The methods for synthesizing these compounds and their intermediates are also detailed in the patent.
Career Highlights
David Robert Luthin is associated with Agouron Pharmaceuticals, Inc., where he has contributed to innovative research and development in the pharmaceutical industry. His expertise in the field has led to advancements that benefit medical science and patient care.
Collaborations
Luthin has worked alongside notable colleagues such as Mark Brian Anderson and Haresh N Vazir. Their collaborative efforts have furthered research in the area of reproductive health and hormone regulation.
Conclusion
David Robert Luthin's work in developing non-peptide GnRH agents showcases his commitment to advancing medical science. His contributions have the potential to significantly impact the treatment of reproductive disorders and hormone-related conditions.